肿瘤微环境中靶向调节性T细胞免疫治疗策略(6)
[33] Rech AJ，Mick R，Recio A，et al. Phase I study of anti-CD25 mab daclizumab to deplete regulatory T cells prior to telomerase/survivin peptide vaccination in patients (pts) with metastatic breast cancer (MBC)[J]. Journal of Clinical Oncology ......
您现在查看是摘要页，全文长 2113 字符。